The blood biomarker breakthrough in Alzheimer’s disease: what applications in 2026? Part I: Blood biomarkers transitioning to clinical practice
- DOI
- 10.1684/abc.2026.2068
- Published
- 2026-10
- Container
- Annales de Biologie Clinique
- Publisher
- JLE
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1684/abc.2026.2068,
title = {The blood biomarker breakthrough in Alzheimer’s disease: what applications in 2026? Part I: Blood biomarkers transitioning to clinical practice},
author = {Aurélie Bedel and Elodie Bouaziz-Amar and Olivier Bousiges and Constance Delaby and Anne Fogli and Aurélie Hanin and Foudil Lamari and Elie Lefranc and Audrey Le Gouellec and Sylvain Lehmann and Catherine Malaplate and Antoine Puravet and Isabelle Quadrio and Pia-Manuela Rusu and Susanna Schraen-Maschke},
year = {2026},
journal = {Annales de Biologie Clinique},
doi = {10.1684/abc.2026.2068},
url = {https://doi.org/10.1684/abc.2026.2068}
}RIS
TY - JOUR TI - The blood biomarker breakthrough in Alzheimer’s disease: what applications in 2026? Part I: Blood biomarkers transitioning to clinical practice AU - Aurélie Bedel AU - Elodie Bouaziz-Amar AU - Olivier Bousiges AU - Constance Delaby AU - Anne Fogli AU - Aurélie Hanin AU - Foudil Lamari AU - Elie Lefranc AU - Audrey Le Gouellec AU - Sylvain Lehmann AU - Catherine Malaplate AU - Antoine Puravet AU - Isabelle Quadrio AU - Pia-Manuela Rusu AU - Susanna Schraen-Maschke PY - 2026 JO - Annales de Biologie Clinique DO - 10.1684/abc.2026.2068 UR - https://doi.org/10.1684/abc.2026.2068 ER -
APA
Bedel, A., Bouaziz-Amar, E., Bousiges, O., Delaby, C., Fogli, A., Hanin, A., Lamari, F., Lefranc, E., Gouellec, A. L., Lehmann, S., Malaplate, C., Puravet, A., Quadrio, I., Rusu, P., & Schraen-Maschke, S. (2026). The blood biomarker breakthrough in Alzheimer’s disease: what applications in 2026? Part I: Blood biomarkers transitioning to clinical practice. Annales de Biologie Clinique. https://doi.org/10.1684/abc.2026.2068
Source records
- crossref · retrieved 2026-11-05T14:45:13.052Z